ARVN

Arvinas, Inc
Data: 2026-06-03
$7.7
Price
-3.75%
Change
$14.51
52W High
$6.06
52W Low

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Quick Stats
Jun 03, 2026

44.9

AI Score

HOLD

1.47

Volume Ratio

Aug 05, 2026

Next Earnings

8

+ve Days (30d)

21

-ve Days (30d)

ARVN Stock Summary

Last updated Jun 03, 2026

ARVN is currently trading at $7.7, positioned below its 200-day moving average of $10.67, suggesting bearish momentum. The stock has a 52-week range of $6.055 to $14.51.

Technical Analysis: The 50-day moving average stands at $10.06, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 24.141, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.307, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ARVN at 44.9/100 with a HOLD recommendation.

ARVN (Arvinas, Inc) Indicators

Last updated Jun 03, 2026

Indicator Value
RSI(14) 24.141
CMF (20) -0.307
ROC (10) -11.345
ADX (14) 24.855
Indicator Value
MACD (12,26,9) -0.604
AROONOSC (14) -100.0
WILLAMS %R (14) -99.145
MFI (14) 27.354
ARVN Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ARVN Price vs Max Options Open Interest
ARVN Max Change In Options Open Interest

ARVN Options - Sort by Max open Interest (near term)

3rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ARVN Daily Out of Money Options - Sort by Max open Interest (near term)

3rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ARVN Daily In the Money Options - Sort by Max open Interest (near term)

3rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ARVN Most Active Options by Volume(near term)

3rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Arvinas, Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

ARVN Moving Averages Analysis

ARVN (Arvinas, Inc) Simple Moving Averages

Moving Averages are last updated Jun 03, 2026

Days MA
10 8.72
20 9.13
30 9.54
50 10.06
100 11.37
200 10.67

ARVN Fundamental Analysis

P/E (Forward) 17.8571
P/E (Trailing) --
Market Cap ($) 516.2 million
Earnings/Share ($) -3.18
Net Proft Margin (%) -2.4754
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.8967
EPS Estimate Next Year ($) -3.3293
WallStreet Target Price ($) 15
Most Recent Quarter